Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $3.1 million.

  • Bicycle Therapeutics' Non-cash Items fell 9289.6% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 9289.6%. This contributed to the annual value of $5.4 million for FY2024, which is 7555.18% down from last year.
  • Bicycle Therapeutics' Non-cash Items amounted to $3.1 million in Q3 2025, which was down 9289.6% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Non-cash Items ranged from a high of $207.0 million in Q4 2021 and a low of $2.2 million during Q2 2021
  • In the last 5 years, Bicycle Therapeutics' Non-cash Items had a median value of $18.5 million in 2022 and averaged $42.8 million.
  • In the last 5 years, Bicycle Therapeutics' Non-cash Items soared by 89954.9% in 2024 and then tumbled by 9289.6% in 2025.
  • Bicycle Therapeutics' Non-cash Items (Quarter) stood at $207.0 million in 2021, then plummeted by 65.7% to $71.0 million in 2022, then tumbled by 69.13% to $21.9 million in 2023, then plummeted by 75.55% to $5.4 million in 2024, then plummeted by 42.56% to $3.1 million in 2025.
  • Its Non-cash Items was $3.1 million in Q3 2025, compared to $2.7 million in Q2 2025 and $3.3 million in Q1 2025.